High Stakes and Tough Decisions with 2019 Novel Coronavirus: One View of Pandemic Planning and Response

Chief Technology Officer, Flu Lab


Julie Schafer, PhD, MPH

Wednesday, February 26, 2020  |  12:15 - 1:45 pm  |  Bass Lecture Hall, The LBJ School


The emergence of the virus causing the COVID-19 epidemic in China (2019 novel coronavirus), with cases around the world, is the latest example of the significant human cost and destabilizing economic and social effects of infectious disease outbreaks. In an interconnected and interdependent world, outbreaks of influenza, Zika, or Ebola in one area can quickly be felt everywhere.

Please join this discussion on the tough decisions governments face in planning for, and responding to, emerging infectious diseases, what tools are available to respond, and what is still needed to prevent futurepandemics.

Julie Schafer, PhD, MPH, is the Chief Technology Officer for Flu Lab, seeking to stretch the boundaries of how technology is used toward defeating influenza. Julie has held a number of leadership positions in the US Government, including Chief of Staff, and later Director of Strategy, for the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services (HHS). Julie served in the White House National Security Council and has led complex influenza vaccine, therapeutic, and diagnostic advanced development programs.